US genetic test report to get government scrutiny:
This article was originally published in Clinica
Executive Summary
There could be a quick response to recommendations by a National Institutes of Health and Department of Energy working group on genetic testing in the US (see Clinica No 780, pp 1-2). Health and Human Services Secretary Donna Shalala has asked senior staff to report back to her by the end of the year on how to respond to the report, Promoting Safe and Effective Genetic Testing in the United States, which calls for tougher regulation of the genetic testing industry. "There was a lot of interest in the findings," said the report's editor, Neil Holzman.
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.